|
Send Inquiry
+919016820285Contact Us For Help
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Daclatasvir Dihydrochloride Tablets 60mg
Product Details:
- Dosage As Directed By Physician.
- Dosage Guidelines As Directed By Physician.
- Suitable For Adults
- Storage Instructions Store in a cool and dark place.
- Supply Ability : 1000000 Box Per Month
36.35 USD ($)
X
Price And Quantity
- As required by client. Box
- 36.35 USD ($)
Product Specifications
- As Directed By Physician.
- Store in a cool and dark place.
- As Directed By Physician.
- Adults
Trade Information
- Hazira / Nhava Sheva
- Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)
- 1000000 Box Per Month
- 1-2 Week
- Yes
- If order is confirmed we will reimburse the sample cost
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
- WHO-GMP/ GMP/ COA/ As Required By Client
Product Description
We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of Daclacure 60mg (Daclatasvir 60mg )Tablets in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
COMPOSITION :
Daclacure 60mg (Daclatasvir 60mg )Tablets
- Brand name: Daclacure
- Active Ingredients(Generic Name) : Daclatasvir 60mg
- Company Name: Emcure Pharma
- Strength : 60 mg
- Package: 28 tabs
- Pack Type: Bottle
Daclacure 60mg (Daclatasvir 60mg )Tablets
is an inhibitor of non-structural protein 5A (NS5A). Each film-coated tablet contains Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg. Daclatasvir is white to yellow color solid and freely soluble in water. Daclatasvir is prescribed for the treatment of patients with chronic HCV genotype 3 infections along with Sofosbuvir 400mg tablets. Daclatasvir has revolutionized the management of HEPATITIS C by offering Ribavirin and Peg-free treatment for all the genotypes of Hepatitis C.
Uses:-Daclacure 60mg (Daclatasvir 60mg )Tablets
is indicated for use, with sofosbuvir, for the treatment of patients with chronic HCV genotype 3. For patients without cirrhosis, the recommended treatment course is 12 weeks. For patients with cirrhosis, the optimal dosing duration of therapy is not known. Use of daclatasvir is contraindicated for use with drugs that are strong inducers of CYP3A
Available other Brand : Natdac ,mydacla ,Hepcfix ,Declahep
We are manufacture and export of our brand. We also offer private labeling, Contract manufacturing service.
Other Products in 'Hepatitis C Medicine' category
Contact Details
- Reg. Office : Office No. U.G - 81, Diamond World, Tower-A, Near Prince Plaza, Mini Bazaar, Varachha Road, Surat - 395006, Gujarat, India
- Corp. office :
#803, Shubh Square,Patelwadi-3, Near Lal Darwaja,Surat - 395004 (Gujarat) India. -
Send Inquiry
- Phone :+918037303586
- Mr Viral Dhaduk (Director)
- Mobile :918037303586
Send Inquiry
Send SMS
Call Me Free
 |
SALVAVIDAS PHARMACEUTICAL PVT. LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Ltd. |